The Perspective of Exosomal MicroRNAs as Biomarkers for Preclinical Alzheimer’s Disease
Author:
- 13 June 2022
- journal article
- editorial
- Published by Elsevier in Biological Psychiatry
- Vol. 92 (1) , 5-7
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Exosomal MicroRNA-Based Predictive Model for Preclinical Alzheimer’s Disease: A Multicenter StudyBiological Psychiatry, 2022
- Effects of exosomal miRNAs in the diagnosis and treatment of Alzheimer’s diseaseMechanisms of Ageing and Development, 2021
- Prediction of future Alzheimer’s disease dementia using plasma phospho-tau combined with other accessible measuresNature Medicine, 2021
- Isolation and characterization of exosomes for cancer researchJournal of Hematology & Oncology, 2020
- microRNA diagnostic panel for Alzheimer’s disease and epigenetic trade-off between neurodegeneration and cancerAgeing Research Reviews, 2019
- Blood-based biomarkers for Alzheimer disease: mapping the road to the clinicNature Reviews Neurology, 2018
- NIA‐AA Research Framework: Toward a biological definition of Alzheimer's diseaseAlzheimer's & Dementia, 2018
- Metazoan MicroRNAsCell, 2018
- Extracellular vesicles in neurodegenerative disease — pathogenesis to biomarkersNature Reviews Neurology, 2016
- The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's diseaseAlzheimer's & Dementia, 2011